Mobile app to manage swelling in kidney patients
Official title: Diuretic Tuner Clinical Decision Support Mobile Device Application for Diuretic Titration in Hypervolemic States
Run by University of Texas Southwestern Medical Center · NCT04759274 · Data updated 2026-11-12
This study tests a mobile app that helps kidney patients manage swelling by adjusting their diuretic medication and tracking their daily health data.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | University of Texas Southwestern Medical Center Academic / other |
| Locations | 1 site (Dallas, Texas) |
| Status | Recruiting |
| Started | November 20, 2023 |
| Main results expected | August 2028 |
| Study ends | August 2028 |
| Registry record updated | October 29, 2026 |
| Trial ID | NCT04759274 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with nephrotic syndrome or stage 4 to 5 chronic kidney disease who exhibit signs of hypervolemia.
✕Probably not a fit
Patients with severe electrolyte imbalances or those unable to monitor their weight and blood pressure at home may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of a mobile application designed to assist patients with kidney issues in managing body swelling through diuretic medication adjustments. Participants will receive the app and training on its use, requiring them to log daily blood pressure and weight. The app will provide personalized guidance based on their health data and will track medication compliance. The study will last for 90 days, with periodic blood tests and a final survey to assess outcomes.
Why it matters
Potential benefit: If successful, this approach could significantly improve the management of edema and fluid retention in patients with chronic kidney diseases.
How similar studies have gone: While this approach is innovative, similar studies utilizing mobile health applications for chronic disease management have shown promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * The presence of nephrotic range proteinuria (\> 3 g/d proteinuria by 24hr urine protein, 24hr urine albumin, spot urine protein/creatinine ratio, or spot urine albumin/creatinine ratio) or stage 4 or 5 chronic kidney disease (estimated glomerular filtration rate \< 30 mL/min/1.73 m2 by Modification of Diet in Renal Disease equation) PLUS * Clinical signs of hypervolemia present (lower extremity edema, ascites, or pleural effusions) with an estimated dry weight (defined as edema-free weight without orthostatic hypotension) 5 lbs less than enrollment body weight Exclusion Criteria: * Weight \< 100 lbs or \> 300 lbs. * Autonomic insufficiency resulting in orthostatic hypotension at screening * Hypokalemia at enrollment (defined as serum potassium \< 3.5 mmol/L) * Moderate to severe hyponatremia at enrollment (defined as serum sodium \< 130 mmol/L) * Serum creatinine \> 6 mg/dL or \> 1.5 times baseline * Patients who are unable or unwilling to measure their home blood pressures and weights * Patients without a working phone number and smart phone device * Expectation that the patient will require dialysis initiation within \< 3 months * Expected lifespan of \< 6 months * The presence of a medical condition that would interfere with effectively using the Diuretic Tuner (dementia, illiteracy, or blindness) * Pregnant patients * Prisoners
Where it's running
-
University of Texas Southwestern
Dallas, Texas, United States Recruiting
Study contacts
- Study coordinator: Kamalanathan K Sambandam, M.D.
- Email: ksambandam@utsouthwestern.edu
- Phone: 214-645-6190
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exploring experiences of patients and parents dealing with swelling from Nephrotic Syndrome
This study talks to patients and parents about their experiences with swelling from Nephrotic Syndrome to help create better ways to measure how new treatments work.
-
Clinical decision support to help consider SGLT2 inhibitors after AKI in type 2 diabetes
This pilot test checks if a CDS message given to clinicians can help decide whether to consider SGLT2 inhibitors for adults with type 2 diabetes who recently had acute kidney injury.
-
Impact of TAVR on kidney function in people with aortic valve disease
This registry tests how trans-catheter aortic valve implantation affects kidney function and the risk of kidney injury in adults with aortic stenosis.
-
Smartphone app to help follow the 2024 KDIGO chronic kidney disease guidelines
This project will test whether a smartphone app helps young adults (ages 16–29) with chronic kidney disease follow the 2024 KDIGO guideline recommendations.
-
Calciphylaxis in people with chronic kidney disease: causes, risks, and early signs
This project will compare adults with chronic kidney disease who develop calciphylaxis to matched CKD patients who do not, collecting clinical data and biological samples to try to find risk factors and early signs.
-
Kidney and liver blood flow patterns after major trauma
We will use bedside ultrasound to see whether abnormal kidney and liver blood flow patterns occur in adults admitted to the ICU after major trauma and whether those patterns link to acute kidney injury or the need for mechanical ventilation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.